Riskpilot← Back to searchSign inGet full accessCARDIA NORDIC ApS
APSDissolvedCVR 36419156Sydvestvej 98Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20141 employees
Revenue 2021
DKK 215K
-76% vs 2020
EBITDA margin
100.0%
-75% vs 2020
Equity ratio
-3.1%
Financial strength
Net profit 2021
DKK 99K
-85% vs 2020
| Revenue | DKK 215K | -76% |
| EBITDA | DKK 215K | -75% |
| Net profit | DKK 99K | -85% |
| Total assets | DKK 2M | +7% |
| Equity | DKK -62K | +62% |
| Employees | 1 | — |
Legal name
CARDIA NORDIC ApS
CVR number
36419156
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
29. oktober 2014
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af 1 direktør
Address
Sydvestvej 98
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.386 | 1.120 | 1.286 | 878 | 215 |
| Staff expenses | -1.254 | -940 | -1.925 | -0 | -0 |
| EBITDA | 132 | 179 | -639 | 863 | 215 |
| Depreciation & amort. | -23 | -15 | -243 | -158 | -48 |
| EBIT | 109 | 165 | -882 | 705 | 167 |
| Net financials | -21 | -34 | -211 | -207 | -39 |
| Profit before tax | 88 | 131 | -1.093 | 499 | 128 |
| Tax | 19 | 31 | -0 | -180 | 28 |
| Net profit | 69 | 100 | -1.093 | 678 | 99 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 3.095 | 2.002 | 1.472 | 1.863 | 1.997 |
| Equity | 476 | 576 | -840 | -161 | -62 |
| Long-term debt | 45 | 123 | 0 | 0 | 0 |
| Short-term debt | 2.519 | 1.340 | 2.226 | 2.024 | 2.059 |
| Total debt | 2.564 | 1.340 | 2.226 | 2.024 | 2.059 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20172021
Equity ratio
-3.1%
This company
38.2%
Market median
-108% vs market
20172021
Return on equity
9924300.0%
This company
18.4%
Market median
+53936313% vs market
20172021
Net profit margin
46.2%
This company
8.1%
Market median
+470% vs market
20172021
Asset turnover
0.11×
This company
1.12×
Market median
-90% vs market
20172021
Debt / equity
33.15×
This company
0.62×
Market median
-5247% vs market
20172021
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
| Name | Role | Member since |
|---|---|---|
| Former (5) | ||
CF Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
JJ Chief Executive Officer | Chief Executive Officer | 2015 – 2019 |
RD Management | Management | 2019 – 2021 |
KK Chief Executive Officer | Chief Executive Officer | 2014 – 2015 |
TW Management | Management | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Board of Directors | 2017 – 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CARDIA NORDIC ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claus Fibiger | Chief Executive Officer | 0 companies |
| Johan Juncker | Chief Executive Officer | 0 companies |
| Ralf Dujardin | Management | 0 companies |
| Kenneth Krivaa | Chief Executive Officer | 0 companies |
| Tom Würtz Laursen | Management | 0 companies |
| Allan Nørretranders | Board of Directors | 0 companies |